Drug Shortage Report for DEXEDRINE SPANSULE
Report ID | 123123 |
Drug Identification Number | 01924559 |
Brand name | DEXEDRINE SPANSULE SRC 10MG |
Common or Proper name | DEXTROAMPHETAMINE SULFATE |
Company Name | PALADIN PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROAMPHETAMINE SULFATE |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 caps |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-08-27 |
Actual start date | |
Estimated end date | 2020-11-01 |
Actual end date | 2020-10-28 |
Shortage status | Resolved |
Updated date | 2020-10-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-08-27 | English | Compare |
v2 | 2020-08-27 | French | Compare |
v3 | 2020-08-28 | English | Compare |
v4 | 2020-10-01 | English | Compare |
v5 | 2020-10-01 | French | Compare |
v6 | 2020-10-28 | English | Compare |
v7 | 2020-10-28 | French | Compare |
v8 | 2020-10-29 | English | Compare |
Showing 1 to 8 of 8